Financials
- Market Capitalization 32.94 B
- Employee 2 500
- Founded 2002
- CEO Yvonne Greenstreet
- Website www.alnylam.com
- Headquarter Massachusetts, United States
- FIGI BBG000BFGNJ5
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
56.06
Fiyat/satışlar oranı
8.6
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 279 | MRNA Moderna, Inc. - Common Stock | 154.28 USD | +9.93% | -2.85% | +180.87% | +544.71% | 61.59 B USD | ||
| 352 | RVMD Revolution Medicines, Inc. - Common Stock | 209.88 USD | +2.10% | -0.71% | +13.80% | +278.84% | 44.98 B USD | ||
| 482 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 62.32 USD | +1.48% | +0.50% | +7.34% | +67.26% | 27.83 B USD | ||
| 493 | INSM Insmed Incorporated - Common Stock | 121.51 USD | -0.25% | -1.12% | +23.74% | -25.02% | 26.54 B USD |